P-glycoprotein (PGP) polymorphisms and sexual dysfunction in female patients with depression and SSRI-associated sexual side effects

Journal of Sex and Marital Therapy

Volumn 39, Issue 3, 2013, Pages 280-288

  Bly, Michael J ^a   Bishop, Jeffrey R ^b   Thomas, Kelan L H ^c   Ellingrod, Vicki L ^d  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^d UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABCB1 PROTEIN, HUMAN; MULTIDRUG RESISTANCE PROTEIN; SEROTONIN UPTAKE INHIBITOR;

ADOLESCENT; ADULT; ARTICLE; CASE CONTROL STUDY; CHEMICALLY INDUCED DISORDER; FEMALE; GENETIC POLYMORPHISM; GENETICS; HUMAN; MAJOR DEPRESSION; PREVALENCE; SEXUAL DYSFUNCTION; UNITED STATES;

ADOLESCENT; ADULT; CASE-CONTROL STUDIES; DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMANS; P-GLYCOPROTEIN; POLYMORPHISM, GENETIC; PREVALENCE; SEROTONIN UPTAKE INHIBITORS; SEXUAL DYSFUNCTION, PHYSIOLOGICAL; UNITED STATES;

EID: 84876414813     PISSN: 0092623X     EISSN: 15210715     Source Type: Journal    
DOI: 10.1080/0092623X.2011.615896     Document Type: Article

References (13)

1. Ameyaw, M. M., Regateiro, F., Li, T., Liu, X., Tariq, M., Mobarek, A., . . McLeod, H. L. (2001). MDR1 pharmacogenetics: Frequency of the C3435T mutation in exon 26 is significantly influenced by ethnicity. Pharmacogenetics, 11, 217-221.
2. Bishop, J. R., Moline, J., Ellingrod, V. L., Schultz, S. K., & Clayton, A. H. (2006). Serotonin 2A-1438 G/A and G-protein Beta3 subunit C825T polymorphisms in patients with depression and SSRI-associated sexual side-effects. Neuropsychopharmacology, 31, 2281-2288.
3. Clayton, A. H., McGarvey, E. L., & Clavet, G. J. (1997). The Changes in Sexual Functioning Questionnaire (CSFQ): Development, reliability, and validity. Psychopharmacology Bulletin, 33, 731-745.
4. He, S. M., Li, R., Kanwar, J. R., & Zhou, S. F. (2011). Structural and functional properties of human multidrug resistance protein 1 (MRP1/ABCC1). Current Medicinal Chemistry, 18, 439-481.
5. Hoffmeyer, S., Burk, O., von Richter, O., Arnold, H. P., Brockmoller, J., Johne, A., Brinkmann, U. (2000). Functional polymorphisms of the human multidrugresistance gene: Multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo. Proceedings of the National Academy of Sciences of the United States of America, 97, 3473-3478.
6. Kato, M., Fukuda, T., Serretti, A., Wakeno, M., Okugawa, G., Ikenaga, Y., Kinoshita, T. (2008). ABCB1 (MDR1) gene polymorphisms are associated with the clinical response to paroxetine in patients with major depressive disorder. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 32, 398-404.
7. Nikisch, G., Eap, C. B., & Baumann, P. (2008). Citalopram enantiomers in plasma and cerebrospinal fluid of ABCB1 genotyped depressive patients and clinical response: A pilot study. Pharmacological Research, 58, 344-347.
8. Richards, B., Skoletsky, J., Shuber, A. P., Balfour, R., Stern, R. C., Dorkin, H. L., . . Klinger, K. W. (1993). Multiplex PCR amplification from the CFTR gene using DNA prepared from buccal brushes/swabs. Human Molecular Genetics, 2, 159-163.
9. Ronaghi, M. (2003). Pyrosequencing for SNP genotyping. Methods in Molecular Biology, 212, 189-195.
10. Rosenberg, K. P., Bleiberg, K. L., Koscis, J., & Gross, C. (2003). A survey of sexual side effects among severely mentally ill patients taking psychotropic medications: Impact on compliance. Journal of Sex & Marital Therapy, 29, 289-296.
11. Uhr, M., Tontsch, A., Namendorf, C., Ripke, S., Lucae, S., Ising, M., . . Holsboer, F. (2008). Polymorphisms in the drug transporter gene ABCB1 predict antidepressant treatment response in depression. Neuron, 57, 203-209.
12. Urquhart, B. L., & Kim, R. B. (2009). Blood-brain barrier transporters and response to CNS-active drugs. European Journal of Clinical Pharmacology, 65, 1063-1070.
13. Zourkova, A., Ceskova, E., Hadasova, E., & Ravcukova, B. (2007). Links among paroxetine-induced sexual dysfunctions, gender, and CYP2D6 activity. Journal of Sex & Marital Therapy, 33, 343-355.